LMEDD (LataMed AI) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LMEDD LataMed AI Corp LMEDD
26 GF Score
Price $1.36
! 3 Warning Signs
View Full Analysis

What is LataMed AI 5-Year Yield-on-Cost %?

LataMed AI LMEDD +10.57% 26 5-Year Yield-on-Cost % is 0.00 as of Jul. 17, 2026. GuruFocus rates LMEDD with a GF Score™ of 26/100. The stock has 3 warning signs investors should review. Among 1,027 Software companies, LataMed AI ranks worse than 97370.89% on this metric.

LataMed AI's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for LataMed AI's 5-Year Yield-on-Cost % or its related term are showing as below:



LMEDD's 5-Year Yield-on-Cost % is not ranked *
in the Software industry.
Industry Median: 3.05
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

LataMed AI  (OTCPK:LMEDD) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


LataMed AI 5-Year Yield-on-Cost % Related Terms


LMEDD vs KLTR, BZAI, THRY: 5-Year Yield-on-Cost % Comparison

For the Software - Application subindustry, LataMed AI's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LataMed AI 5-Year Yield-on-Cost % vs Software Industry

For the Software industry and Technology sector, LataMed AI's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where LataMed AI's 5-Year Yield-on-Cost % falls into.


LMEDD
26GF Score
LataMed AI Corp LMEDD
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LataMed AI 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of LataMed AI is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
LataMed AI (LMEDD) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 17, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on LataMed AI and its competitors. According to the industry distribution chart, LataMed AI ranks #999999 out of 1027 companies in the Software industry.
Is LataMed AI's 5-Year Yield-on-Cost % too high?
LataMed AI's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, LataMed AI ranks #999999 out of 1027 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, LataMed AI has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does LataMed AI's 5-Year Yield-on-Cost % compare to KLTR and BZAI?
According to the Software industry distribution chart, LataMed AI ranks #999999 out of 1027 companies for 5-Year Yield-on-Cost %. This places LataMed AI in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Software company?
The median 5-Year Yield-on-Cost % among Software companies is 3.05, based on 1,027 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on LataMed AI and its competitors. For the Software industry, the median 5-Year Yield-on-Cost % is 3.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LataMed AI's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LataMed AI stock overvalued right now?
LataMed AI (LMEDD) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. LataMed AI's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For LataMed AI (LMEDD), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LataMed AI Business Description

Address Av. Romulo Gallegos con Av. Las Palmas, Edif. Torre Gerencial Los Andes, Caracas, VEN, 1071
LataMed AI Corp is a technology company focused on the development and deployment of artificial intelligence-driven healthcare solutions across Latin America. Its healthcare platform includes AI-enabled analytics, telehealth infrastructure, and coordinated care systems designed to support healthcare delivery in emerging markets. The company develops digital infrastructure for patient prioritization, clinical workflow management, telehealth access, care coordination, and healthcare system operations. It holds issued patents for its core AI modules-CardioAI, PulmoAI, and NeuroAI-which deliver predictive analytics for cardiovascular, pulmonary, and neurological disease detection and management.
26GF Score

Get the complete analysis for LMEDD

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.36
Price